Works by Chen-Plotkin, Alice S.


Results: 37
    1
    2
    3
    4
    5

    Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.

    Published in:
    Movement Disorders, 2021, v. 36, n. 12, p. 2945, doi. 10.1002/mds.28779
    By:
    • Aamodt, Whitley W.;
    • Waligorska, Teresa;
    • Shen, Junchao;
    • Tropea, Thomas F.;
    • Siderowf, Andrew;
    • Weintraub, Daniel;
    • Grossman, Murray;
    • Irwin, David;
    • Wolk, David A.;
    • Xie, Sharon X.;
    • Trojanowski, John Q.;
    • Shaw, Leslie M.;
    • Chen‐Plotkin, Alice S.
    Publication type:
    Article
    6
    7

    Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype.

    Published in:
    Movement Disorders, 2015, v. 30, n. 6, p. 805, doi. 10.1002/mds.26022
    By:
    • Swanson, Christine R.;
    • Li, Katherine;
    • Unger, Travis L.;
    • Gallagher, Michael D.;
    • Van Deerlin, Vivianna M.;
    • Agarwal, Pinky;
    • Leverenz, James;
    • Roberts, John;
    • Samii, Ali;
    • Gross, Rachel Goldmann;
    • Hurtig, Howard;
    • Rick, Jacqueline;
    • Weintraub, Daniel;
    • Trojanowski, John Q.;
    • Zabetian, Cyrus;
    • Chen‐Plotkin, Alice S.
    Publication type:
    Article
    8

    Genetic influences on cognitive decline in Parkinson's disease.

    Published in:
    Movement Disorders, 2012, v. 27, n. 4, p. 512, doi. 10.1002/mds.24946
    By:
    • Morley, James F.;
    • Xie, Sharon X.;
    • Hurtig, Howard I.;
    • Stern, Matthew B.;
    • Colcher, Amy;
    • Horn, Stacy;
    • Dahodwala, Nabila;
    • Duda, John E.;
    • Weintraub, Daniel;
    • Chen-Plotkin, Alice S.;
    • Van Deerlin, Vivianna;
    • Falcone, Dana;
    • Siderowf, Andrew
    Publication type:
    Article
    9
    10

    Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau<sub>181</sub>, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease.

    Published in:
    JAMA Neurology, 2013, v. 70, n. 10, p. 1277, doi. 10.1001/jamaneurol.2013.3861
    By:
    • Ju-Hee Kang;
    • Irwin, David J.;
    • Chen-Plotkin, Alice S.;
    • Siderowf, Andrew;
    • Caspell, Chelsea;
    • Coffey, Christopher S.;
    • Waligórska, Teresa;
    • Taylor, Peggy;
    • Pan, Sarah;
    • Frasier, Mark;
    • Marek, Kenneth;
    • Kieburtz, Karl;
    • Jennings, Danna;
    • Simuni, Tanya;
    • Tanner, Caroline M.;
    • Singleton, Andrew;
    • Toga, Arthur W.;
    • Chowdhury, Sohini;
    • Mollenhauer, Brit;
    • Trojanowski, John Q.
    Publication type:
    Article
    11
    12
    13

    Finding useful biomarkers for Parkinson's disease.

    Published in:
    Science Translational Medicine, 2018, v. 10, n. 454, p. 1, doi. 10.1126/scitranslmed.aam6003
    By:
    • Chen-Plotkin, Alice S.;
    • Albin, Roger;
    • Alcalay, Roy;
    • Babcock, Debra;
    • Bajaj, Vikram;
    • Bowman, Dubois;
    • Buko, Alex;
    • Cedarbaum, Jesse;
    • Chelsky, Daniel;
    • Cookson, Mark R.;
    • Dawson, Ted M.;
    • Dewey, Richard;
    • Foroud, Tatiana;
    • Frasier, Mark;
    • German, Dwight;
    • Gwinn, Katrina;
    • Huang, Xuemei;
    • Kopil, Catherine;
    • Kremer, Thomas;
    • Lasch, Shirley
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease.

    Published in:
    Annals of Neurology, 2022, v. 92, n. 2, p. 255, doi. 10.1002/ana.26410
    By:
    • Shen, Junchao;
    • Amari, Noor;
    • Zack, Rebecca;
    • Skrinak, R. Tyler;
    • Unger, Travis L.;
    • Posavi, Marijan;
    • Tropea, Thomas F.;
    • Xie, Sharon X.;
    • Van Deerlin, Vivianna M.;
    • Dewey, Richard B.;
    • Weintraub, Daniel;
    • Trojanowski, John Q.;
    • Chen‐Plotkin, Alice S.
    Publication type:
    Article
    21

    Plasma apolipoprotein A1 as a biomarker for Parkinson disease.

    Published in:
    Annals of Neurology, 2013, v. 74, n. 1, p. 119, doi. 10.1002/ana.23872
    By:
    • Qiang, Judy K.;
    • Wong, Yvette C.;
    • Siderowf, Andrew;
    • Hurtig, Howard I.;
    • Xie, Sharon X.;
    • Lee, Virginia M.‐Y.;
    • Trojanowski, John Q.;
    • Yearout, Dora;
    • B. Leverenz, James;
    • Montine, Thomas J.;
    • Stern, Matt;
    • Mendick, Susan;
    • Jennings, Danna;
    • Zabetian, Cyrus;
    • Marek, Ken;
    • Chen‐Plotkin, Alice S.
    Publication type:
    Article
    22

    Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.

    Published in:
    Annals of Neurology, 2011, v. 69, n. 4, p. 655, doi. 10.1002/ana.22271
    By:
    • Chen-Plotkin, Alice S.;
    • Hu, William T.;
    • Siderowf, Andrew;
    • Weintraub, Daniel;
    • Goldmann Gross, Rachel;
    • Hurtig, Howard I.;
    • Xie, Sharon X.;
    • Arnold, Steven E.;
    • Grossman, Murray;
    • Clark, Christopher M.;
    • Shaw, Leslie M.;
    • McCluskey, Leo;
    • Elman, Lauren;
    • Van Deerlin, Vivianna M.;
    • Lee, Virginia M.-Y.;
    • Soares, Holly;
    • Trojanowski, John Q.
    Publication type:
    Article
    23

    Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes.

    Published in:
    Annals of Clinical & Translational Neurology, 2025, v. 12, n. 5, p. 925, doi. 10.1002/acn3.52286
    By:
    • Zhang, Hanwen;
    • Kargilis, Daniel;
    • Tropea, Thomas;
    • Robinson, John;
    • Shen, Junchao;
    • Brody, Eliza M.;
    • Brinkmalm, Ann;
    • Sjödin, Simon;
    • Berndt, Adama J.;
    • Carceles‐Cordon, Marc;
    • Suh, EunRan;
    • Van Deerlin, Vivianna M.;
    • Blennow, Kaj;
    • Weintraub, Daniel;
    • Lee, Edward B.;
    • Zetterberg, Henrik;
    • Chen‐Plotkin, Alice S.
    Publication type:
    Article
    24

    Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease.

    Published in:
    Annals of Clinical & Translational Neurology, 2024, v. 11, n. 3, p. 673, doi. 10.1002/acn3.51988
    By:
    • Arezoumandan, Sanaz;
    • Cousins, Katheryn A.Q.;
    • Ohm, Daniel T.;
    • Lowe, MaKayla;
    • Chen, Min;
    • Gee, James;
    • Phillips, Jeffrey S.;
    • McMillan, Corey T.;
    • Luk, Kelvin C.;
    • Deik, Andres;
    • Spindler, Meredith A.;
    • Tropea, Thomas F.;
    • Weintraub, Daniel;
    • Wolk, David A.;
    • Grossman, Murray;
    • Lee, Virginia;
    • Chen‐Plotkin, Alice S.;
    • Lee, Edward B.;
    • Irwin, David J.
    Publication type:
    Article
    25

    Plasma phosphorylated tau181 predicts cognitive and functional decline.

    Published in:
    Annals of Clinical & Translational Neurology, 2023, v. 10, n. 1, p. 18, doi. 10.1002/acn3.51695
    By:
    • Tropea, Thomas F.;
    • Waligorska, Teresa;
    • Xie, Sharon X.;
    • Nasrallah, Ilya M.;
    • Cousins, Katheryn A. Q.;
    • Trojanowski, John Q.;
    • Grossman, Murray;
    • Irwin, David J.;
    • Weintraub, Daniel;
    • Lee, Edward B.;
    • Wolk, David A.;
    • Chen‐Plotkin, Alice S.;
    • Shaw, Leslie M.
    Publication type:
    Article
    26

    Genetic prediction of impulse control disorders in Parkinson's disease.

    Published in:
    Annals of Clinical & Translational Neurology, 2022, v. 9, n. 7, p. 936, doi. 10.1002/acn3.51569
    By:
    • Weintraub, Daniel;
    • Posavi, Marijan;
    • Fontanillas, Pierre;
    • Tropea, Thomas F.;
    • Mamikonyan, Eugenia;
    • Suh, Eunran;
    • Trojanowski, John Q.;
    • Cannon, Paul;
    • Van Deerlin, Vivianna M.;
    • Chen‐Plotkin, Alice S.
    Publication type:
    Article
    27

    Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype.

    Published in:
    Annals of Clinical & Translational Neurology, 2017, v. 4, n. 1, p. 15, doi. 10.1002/acn3.371
    By:
    • Cooper, Christine A.;
    • Jain, Nimansha;
    • Gallagher, Michael D.;
    • Weintraub, Daniel;
    • Xie, Sharon X.;
    • Berlyand, Yosef;
    • Espay, Alberto J.;
    • Quinn, Joseph;
    • Edwards, Karen L.;
    • Montine, Thomas;
    • Van Deerlin, Vivianna M.;
    • Trojanowski, John;
    • Zabetian, Cyrus P.;
    • Chen‐Plotkin, Alice S.
    Publication type:
    Article
    28

    Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease.

    Published in:
    Annals of Clinical & Translational Neurology, 2016, v. 3, n. 5, p. 346, doi. 10.1002/acn3.299
    By:
    • Lim, Nicholas S.;
    • Swanson, Christine R.;
    • Cherng, Hua‐Ren;
    • Unger, Travis L.;
    • Xie, Sharon X.;
    • Weintraub, Daniel;
    • Marek, Ken;
    • Stern, Matthew B.;
    • Siderowf, Andrew;
    • Trojanowski, John Q.;
    • Chen‐Plotkin, Alice S.
    Publication type:
    Article
    29
    30
    31

    Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.

    Published in:
    PLoS Medicine, 2019, v. 16, n. 10, p. 1, doi. 10.1371/journal.pmed.1002931
    By:
    • Posavi, Marijan;
    • Diaz-Ortiz, Maria;
    • Liu, Benjamine;
    • Swanson, Christine R.;
    • Skrinak, R. Tyler;
    • Hernandez-Con, Pilar;
    • Amado, Defne A.;
    • Fullard, Michelle;
    • Rick, Jacqueline;
    • Siderowf, Andrew;
    • Weintraub, Daniel;
    • McCluskey, Leo;
    • Trojanowski, John Q.;
    • Dewey, Richard B.;
    • Huang, Xuemei;
    • Chen-Plotkin, Alice S.
    Publication type:
    Article
    32
    33

    Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.

    Published in:
    Nature, 2010, v. 466, n. 7310, p. 1069, doi. 10.1038/nature09320
    By:
    • Elden, Andrew C.;
    • Kim, Hyung-Jun;
    • Hart, Michael P.;
    • Chen-Plotkin, Alice S.;
    • Johnson, Brian S.;
    • Fang, Xiaodong;
    • Armakola, Maria;
    • Geser, Felix;
    • Greene, Robert;
    • Lu, Min Min;
    • Padmanabhan, Arun;
    • Clay-Falcone, Dana;
    • McCluskey, Leo;
    • Elman, Lauren;
    • Juhr, Denise;
    • Gruber, Peter J.;
    • Rüb, Udo;
    • Auburger, Georg;
    • Trojanowski, John Q.;
    • Lee, Virginia M.-Y.
    Publication type:
    Article
    34

    Cerebrospinal fluid α‐synuclein contributes to the differential diagnosis of Alzheimer's disease.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 8, p. 1052, doi. 10.1016/j.jalz.2018.02.015
    By:
    • Shi, Min;
    • Tang, Lu;
    • Toledo, Jon B.;
    • Ginghina, Carmen;
    • Wang, Hua;
    • Aro, Patrick;
    • Jensen, Poul H.;
    • Weintraub, Daniel;
    • Chen‐Plotkin, Alice S.;
    • Irwin, David J.;
    • Grossman, Murray;
    • McCluskey, Leo;
    • Elman, Lauren B.;
    • Wolk, David A.;
    • Lee, Edward B.;
    • Shaw, Leslie M.;
    • Trojanowski, John Q.;
    • Zhang, Jing
    Publication type:
    Article
    35

    GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders.

    Published in:
    Movement Disorders, 2024, v. 39, n. 6, p. 1065, doi. 10.1002/mds.29773
    By:
    • Brody, Eliza M.;
    • Seo, Yunji;
    • Suh, EunRan;
    • Amari, Noor;
    • Hartstone, Whitney G.;
    • Skrinak, R. Tyler;
    • Zhang, Hanwen;
    • Diaz‐Ortiz, Maria E.;
    • Weintraub, Daniel;
    • Tropea, Thomas F.;
    • Van Deerlin, Vivianna M.;
    • Chen‐Plotkin, Alice S.
    Publication type:
    Article
    36
    37